Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
Authors
Keywords
-
Journal
Lancet Gastroenterology & Hepatology
Volume 7, Issue 2, Pages 118-127
Publisher
Elsevier BV
Online
2021-11-17
DOI
10.1016/s2468-1253(21)00294-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sa447 RESOLUTION IN GENE SIGNATURES ASSOCIATED WITH INFLAMMATORY IMMUNE CELL INFILTRATES, ACTIVATED FIBROBLASTS AND EPITHELIAL RECOVERY IN TNF-NAIVE AND TNF-IR UC PATIENTS TREATED WITH ETROLIZUMAB
- (2021) Courtney Schiffman et al. GASTROENTEROLOGY
- Positioning therapies in ulcerative colitis
- (2020) Silvio Danese et al. Clinical Gastroenterology and Hepatology
- Head-to-head trials in inflammatory bowel disease: past, present and future
- (2020) Lieven Pouillon et al. Nature Reviews Gastroenterology & Hepatology
- Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus
- (2019) Silvio Danese et al. DIGESTIVE DISEASES
- Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview
- (2019) Lieven Pouillon et al. BMC Medicine
- The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies
- (2019) Iris Dotan et al. MEDICINAL RESEARCH REVIEWS
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease
- (2018) M. T. Tang et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis
- (2017) Xiaohui Wei et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Ulcerative colitis
- (2017) Ryan Ungaro et al. LANCET
- Overcoming disease-specific matrix effect in a clinical pharmacokinetic assay using a microfluidic immunoassay technology
- (2017) Kathi Williams et al. Bioanalysis
- Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab
- (2016) Konstantinos Papamichael et al. Journal of Crohns & Colitis
- Long-term outcomes of colectomy surgery among patients with ulcerative colitis
- (2015) Carl Brown et al. SpringerPlus
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- Adverse events in IBD: to stop or continue immune suppressant and biologic treatment
- (2014) Leon P McLean et al. Expert Review of Gastroenterology & Hepatology
- A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
- (2012) Paul J Rutgeerts et al. GUT
- A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
- (2011) EG Stefanich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease
- (2009) Kate R. Muller et al. INFLAMMATORY BOWEL DISEASES
- Stratified Wilson and Newcombe Confidence Intervals for Multiple Binomial Proportions
- (2009) Xin Yan et al. Statistics in Biopharmaceutical Research
- General Multistage Gatekeeping Procedures
- (2008) Alex Dmitrienko et al. BIOMETRICAL JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started